G-protein γ 7 is down-regulated in cancers and associated with P 27(kip1)-induced growth arrest

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1096-1101

  Shibata, Kohei ^a   Tanaka, Shinji ^a   Shiraishi, Takeshi ^a   Kitano, Seigo ^b   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN P27;

ARTICLE; CELL CYCLE G1 PHASE; CHROMOSOME LOSS; CONTACT INHIBITION; EFFECTOR CELL; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME INHIBITORS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; KINETICS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033106052     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Neer, E. J. G proteins: critical control points for transmembrane signals. Protein Sci., 3: 3-14, 1994.
2. Rens, D. S., and Hamm, H. E. Structural and functional relationships of heterotrimeric G-proteins. FASEB J., 9: 1059-1066, 1995.
3. Nurnberg, B., and Ahnert, H. G. Potential roles of heterotrimeric G proteins of the endomembrane system. Febs Lett., 389: 61-65, 1996.
4. Wess, J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J., 11: 346-354, 1997.
5. Ueda, N., and Tang, W. J. Conditional regulation of adenylyl cyclases by G- protein βγ-subunits. Biochem. Soc. Trans., 21: 1132-1138, 1993.
6. Clapham, D. E., and Neer, E. J. New roles for G-protein βγ-dimers in transmembrane signaling. Nature (Lond.), 365: 403-406, 1993.
7. Muller, S., and Lohse, M. J. The role of G-protein βγ subunits in signal transduction. Biochem. Soc. Trans., 23: 141-148, 1995.
8. Vallar, L. Oncogenic role of heterotrimeric G proteins. Cancer Surv., 27: 325-338, 1996.
9. Bos, J. L. ras oncogenes in human cancer. Cancer Res., 49: 4682-4689, 1989.
10. Symons, M. The Rac and Rho pathways as a source of drug targets for Ras-mediated malignancies. Curr. Opin. Biotechnol., 6: 668-674, 1995.
11. Boivin, D., Bilodeau, D., and Beliveau, R. Regulation of cytoskeletal functions by Rho small GTP-binding proteins in normal and cancer cells. Can. J. Physiol. Pharmacol., 74: 801-810, 1996.
12. Shibata, K., Mori, M., Tanaka, S., Kitano, S., and Akiyoshi, T. Identification and cloning of human G-protein γ 7, down-regulated in pancreatic cancer. Biochem. Biophys. Res. Commun., 246: 205-209, 1998.
13. Muller, S., Hekman, M., and Lohse, M. J. Specific enhancement of β-adrenergic receptor kinase activity by defined G-protein β and γ subunits. Proc. Natl. Acad. Sci. USA, 90: 10439-10443, 1993.
14. Lee, C., Murakami, T., and Simonds, W. F. Identification of a discrete region of the G protein γ subunit conferring selectivity in βγ complex formation. J. Biol. Chem., 270: 8779-8784, 1995.
15. Backlund, P. J., Simonds, W. F., and Spiegel, A. M. Carboxyl methylation and COOH-terminal processing of the brain G-protein γ-subunit. J. Biol. Chem., 265: 15572-15576, 1990.
16. Maltese, W. A. Posttranslational modification of proteins by isoprenoids in mammalian cells (Review: 66 refs.). FASEB J., 4: 3319-3328, 1990.
17. Newman, P., Kube, E., Gerke, V., and Weber, K. Polyisoprenylation of the CAAX motif: an in vitro protein synthesis study. Biochim. Biophys. Acta, 1080: 227-230, 1991.
18. Simonds, W. F., Butrynski, J. E., Gautam, N., Unson, C. G., and Spiegel, A. M. G-protein βγ dimers. Membrane targeting requires subunit coexpression and intact γ C-A-A-X domain. J. Biol. Chem., 266: 5363-5366, 1991.
19. Symons, M. The Rac and Rho pathways as a source of drug targets for Ras-mediated malignancies (Review: 63 refs.). Curr Opin. Biotech., 6: 668-674, 1995.
20. Cali, J. J., Balcueva, E. A., Rybalkin, I., and Robishaw, J. D. Selective tissue distribution of G protein γ subunits, including a new form of the γ subunits identified by cDNA cloning. J. Biol. Chem., 267: 24023-24027, 1992.
21. Ray, K., Kunsch, C., Bonner, L. M., and Robishaw, J. D. Isolation of cDNA clones encoding eight different human G protein γ subunits, including three novel forms designated the γ 4, γ 10, and γ 11 subunits. J. Biol. Chem., 270: 21765-21771, 1995.
22. Noda, A., Ning, Y., Venable, S. F., Pereira, S. O., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
23. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., and Koff, A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
24. Mori, M., Barnard, G. F., Staniunas, R. J., Jessup, J. M., Steele, G. J., and Chen, L. B. Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene, 8: 2821-2826, 1993.
25. Mori, M., Staniunas, R. J., Barnard, G. F., Jessup, J. M., Steele, G. J., and Chen, L. B. The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology, 105: 820-826, 1993.
26. Mori, M., Mimori, K., Inoue, H., Barnard, G. F., Tsuji, K., Nanbara, S., Ueo, H., and Akiyoshi, T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 55: 3417-3420, 1995.
27. Mori, M., Mimori, K., Ueo, H., Karimine, N., Barnard, G. F., Sugimachi, K., and Akiyoshi, T. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int. J. Cancer, 68: 739-743, 1996.
28. Mori, M., Mimori, K, Shiraishi, T, Tanaka, S, Ueo, H. Sugimachi, K, and Akiyoshi, T. p27 expression and gastric carcinoma. Nat. Med., 3: 593-594, 1997.
29. Clark, K. L., and Sprague, G. J. Yeast pheromone response pathway: characterization of a suppressor that restores mating to receptorless mutants. Mol. Cell. Biol., 9: 2682-2694, 1989.
30. Fujimura, H. A. The yeast G-protein homolog is involved in the mating pheromone signal transduction system. Mol. Cell. Biol., 9: 152-158, 1989.
31. Nomoto, S., Nakayama, N., Arai, K., and Matsumoto, K. Regulation of the yeast pheromone response pathway by G protein subunits. EMBO J., 9: 691-696, 1990.
32. Peter, M.. Gartner, A., Horecka, J., Ammerer, G. and Herskowitz, I. Far 1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell, 73: 747-760, 1993.
33. Whiteway, M., Hougan, L., Dignard, D., Thomas, D. Y., Bell, L., Saari, G. C., Grant, F. J., O'Hara, P., and MacKay, V. L. The STE4 and STE18 genes of yeast encode potential β and γ subunits of the mating factor receptor-coupled G protein. Cell 56: 467-477, 1989.
34. Akada, R., Kallal, L., Johnson, D. I., and Kurjan, J. Genetic relationships between the G protein β γ complex, Ste5p, Ste20p and Cdc42p: investigation of effector roles in the yeast pheromone response pathway. Genetics, 143: 103-117, 1996.
35. Whiteway, M., Hougan, L., and Thomas, D. Y. Overexpression of the STE4 gene leads to mating response in haploid Saccharomyces cerevisiae. Mol. Cell. Biol., 10: 217-222, 1990.
36. Blinder, D., Bouvier, S., and Jenness, D. D. Constitutive mutants in the yeast pheromone response: ordered function of the gene products. Cell, 56: 479-486, 1989.
37. Whiteway, M., Dignard, D., and Thomas, D. Y. Mutagenesis of Ste18, a putative G y subunit in the Saccharomyces cerevisiae pheromone response pathway. Biochem. Cell Biol., 70: 1230-1237, 1992.
38. Grishin, A. V., Weiner, J. L., and Blumer, K. J. Biochemical and genetic analysis of dominant-negative mutations affecting a yeast G-protein γ subunit. Mol. Cell. Biol. 14: 4571-4578, 1994.
39. Whiteway, M. S., and Thomas, D. Y. Site-directed mutations altering the CAAX box of Ste18, the yeast pheromone-response pathway G γ subunit. Genetics, 137: 967-976, 1994.
40. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M., and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas (see comments). Nat. Med. 3: 231-234, 1997.
41. Steeg, P. S., and Abrams, J. S. Cancer prognostics: past, present and p27. Nat. Med., 3: 152-154, 1997.
42. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3: 222-225, 1997.
43. Hoglund, M., Gorunova, L., Andren-Sandberg, A., Mitelman, F., and Johansson, B. Cytogenic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinoma: frequent loss of 19p13.3 and gain of 19p13.1-13.2. Genes Chromosomes Cancer, 21: 8-16, 1998.
44. Ritland, S., Ganju, V., and Jenkins, R. Regeion-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer, 12: 277-282, 1995.
45. Amfo, K., Neyns, B., Teugels, E., Lissens, W., Bourgain, C., De Sutter, P., Van damme, B., Vamos, E., and De Greve, J. Frequent deletion of chromosome 19 and a rare rearrangement of 19pl3.3 involving the insulin receptor gene in human ovarian cancer. Oncogene, 11: 351-358, 1995.
46. Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Houglund, P., Jarvinen, H., Kristo, P., Pelin, K., Ridanpaa, M., Salovaara, R., Toro, T., Bodmer, W., Olschwang, S., Olsen, A., Stratton, M., de la Chapelle, A., and Aaltonen, L. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (Lond.), 391: 184-187, 1998.
47. Jenne, D. E., Reimann, H., Nezu, J. I., Friedel, W., Loff, S., Jeschke, R., Muller, O., Back, W., and Zimmer, M. Peuet-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet., 18: 38-44, 1998.